• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    6/14/24 2:13:08 PM ET
    $ADBE
    $ATI
    $BAND
    $BE
    Computer Software: Prepackaged Software
    Technology
    Steel/Iron Ore
    Industrials
    Get the next $ADBE alert in real time by email

    Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.

    AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for a loss of 1 cent per share. The company reported quarterly sales of $40.42 million topping estimates of $37.90 million, according to data from Benzinga Pro.

    AMMO shares dipped 19.1% to $2.0306 on Friday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares jumped 345% to $6.06.
    • SRIVARU Holding Limited (NASDAQ:SVMH) gained 150% to $0.3852 after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) surged 42.5% to $5.16.
    • FOXO Technologies Inc. (NASDAQ:FOXO) shares gained 29% to $0.3092 after the company announced it entered into share exchange agreements with Rennova Health.
    • Jeffs’ Brands Ltd (NASDAQ:JFBR) surged 29% to $0.4528.
    • BIMI Holdings Inc. (NASDAQ:BIMI) gained 25.7% to $2.15.
    • Longeveron Inc. (NASDAQ:LGVN) rose 23.4% to $3.36.
    • OneMedNet Corporation (NASDAQ:ONMD) gained 20% to $1.4599 as the company announced iRWD customer data license agreement with a leading U.S.-based global clinical trial design and software company.
    • Can-Fite BioPharma Ltd. (NYSE:CANF) jumped 17.9% to $4.28.
    • Disc Medicine, Inc. (NASDAQ:IRON) rose 15.6% to $45.29. Disc Medicine announced a $178 million underwritten offering of 4.944 million shares at $36 per share.
    • Adobe Inc. (NASDAQ:ADBE) rose gained 14.3% to $524.39 following better-than-expected second-quarter earnings and strong guidance.
    • RenovoRx, Inc. (NASDAQ:RNXT) surged 14.3% to $1.2001.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) gained 14.1% to $5.75 as the company highlighted AXPAXLI SOL-1 enrollment and plans repeat dosing study in wet AMD.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) gained 14% to $0.1836 after dipping 17% on Thursday.
    • VinFast Auto Ltd. (NASDAQ:VFS) gained 9.9% to $4.32. VinFast Auto anticipates sustained growth for next five years and approaching break-even point.
    • Tutor Perini Corporation (NYSE:TPC) rose 9.9% to $21.11. UBS analyst Steven Fisher upgraded Tutor Perini from Neutral to Buy and raised the price target from $14 to $27.
    • Willis Lease Finance Corporation (NASDAQ:WLFC) gained 6.4% to $64.99.
    • Hasbro, Inc. (NASDAQ:HAS) gained 5.5% to $61.22 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $70 to $80.

    Losers

    • QXO, Inc. (NASDAQ:QXO) shares dipped 43.3% to $116.47 after announcing a $3.5 billion private placement.
    • Nexalin Technology, Inc. (NASDAQ:NXL) shares fell 33.3% to $0.9192 after jumping 121% on Thursday. Nexalin Technology recently announced regulatory approval of Gen-2 15mA neurostimulation device by Brazilian Health Regulatory Agency.
    • IN8bio, Inc. (NASDAQ:INAB) dipped 31.1% to $1.1598 after the company presented data from its Phase 1 trial of INB-100 showing 100% of treated leukemia patients achieved durable complete remission at 1 year.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) fell 28.1% to $1.3599 after the company announced the pricing of a $11 million public offering of 7,116,547 shares at $1.35 per share and pre-funded warrants.
    • Kyverna Therapeutics, Inc. (NASDAQ:KYTX) dipped 24.8% to $10.88.
    • Rezolute, Inc. (NASDAQ:RZLT) shares fell 24.3% to $3.90 after the company announced pricing of public offering of $60 million of common stock and pre-funded warrants.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) dipped 20.2% to $0.3302.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 20.2% to $5.66. The company announced completion of ADS ratio change.
    • NanoViricides, Inc. (NASDAQ:NNVC) fell 19.3% to $2.08
    • Neo-Concept International Group Holdings Limited (NASDAQ:NCI) shares fell 19.2% to $0.7141 after jumping over 35% on Thursday.
    • Ostin Technology Group Co Ltd (NASDAQ:OST) fell 19.2% to $0.4020 after jumping 24% on Thursday.
    • RH (NYSE:RH) shares fell 18.6% to $225.60 after the company reported mixed first-quarter financial results.
    • Assure Holdings Corp. (NASDAQ:IONM) declined 15.3% to $0.26.
    • Bandwidth Inc. (NASDAQ:BAND) fell 13.1% to $16.07. Morgan Stanley analyst Meta Marshall downgraded Bandwidth from Equal-Weight to Underweight and lowered the price target from $18 to $15.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) dipped 12.5% to $10.99 as the company announced initial clinical data from Phase 1/2 RESET-Myositis and RESET-SLE trials of CABA-201.
    • 2U, Inc. (NASDAQ:TWOU) fell 10.5% to $6.11.
    • Corcept Therapeutics Incorporated (NASDAQ:CORT) dipped 10% to $28.36.
    • Novavax, Inc. (NASDAQ:NVAX) fell 9.7% to $13.59.
    • PENN Entertainment, Inc. (NASDAQ:PENN) fell 9.6% to $17.23. Truist Securities analyst Barry Jonas maintained PENN Entertainment with a Buy and raised the price target from $23 to $25.
    • ATI Inc. (NYSE:ATI) fell 9.6% to $51.65.
    • MSC Industrial Direct Co., Inc. (NYSE:MSM) shares declined 8.3% to $77.48 after the company reported preliminary third-quarter financial results below estimates and cut its FY24 adjusted operating margin.
    • Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell 7.7% to $39.82 as the company announced the pricing of public offering of common stock and pre-funded warrants.
    • WESCO International, Inc. (NYSE:WCC) fell 7.1% to $161.79.
    • Carnival plc (NYSE:CUK) fell 6.7% to $13.89.
    • Bloom Energy Corporation (NYSE:BE) fell 5.7% to $14.23.
    • Telephone and Data Systems, Inc. (NYSE:TDS) fell 5.6% to $18.93

    Now Read This: Dell, Palo Alto Networks And 2 Other Stocks Insiders Are Selling

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ATI
    $BAND
    $BE

    CompanyDatePrice TargetRatingAnalyst
    Bloom Energy Corporation
    $BE
    4/14/2026$187.00Underperform → Hold
    Jefferies
    Adobe Inc.
    $ADBE
    4/13/2026Neutral
    BTIG Research
    ATI Inc.
    $ATI
    4/1/2026$175.00Overweight
    Wells Fargo
    Corcept Therapeutics Incorporated
    $CORT
    3/26/2026Underperform → Peer Perform
    Wolfe Research
    Adobe Inc.
    $ADBE
    3/26/2026Mkt Perform
    William Blair
    ATI Inc.
    $ATI
    3/25/2026$140.00Overweight
    KeyBanc Capital Markets
    Rezolute Inc.
    $RZLT
    3/25/2026$5.00Neutral → Outperform
    Wedbush
    RH
    $RH
    3/25/2026$185.00 → $165.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $ADBE
    $ATI
    $BAND
    $BE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:21 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:19 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Arkley Peter bought $1,824,002 worth of shares (25,000 units at $72.96), increasing direct ownership by 13% to 216,717 units (SEC Form 4)

    4 - TUTOR PERINI CORP (0000077543) (Issuer)

    3/6/26 5:05:45 PM ET
    $TPC
    General Bldg Contractors - Nonresidential Bldgs
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:21 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:19 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form 4 filed by Weinstein Joshua Ian

    4 - CARNIVAL PLC (0001125259) (Issuer)

    4/23/26 11:43:30 AM ET
    $CUK
    Marine Transportation
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    SEC Filings

    View All

    SEC Form 6-K filed by Can-Fite Biopharma Ltd

    6-K - Can-Fite BioPharma Ltd. (0001536196) (Filer)

    4/23/26 4:15:11 PM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hasbro Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HASBRO, INC. (0000046080) (Filer)

    4/23/26 7:00:35 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    PENN Entertainment Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PENN Entertainment, Inc. (0000921738) (Filer)

    4/23/26 7:00:10 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

    BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced an oral presentation at the 3rd International GBA1 Meeting 2026, being held May 22-23, 2026, in Phoenix, AZ. Details of the oral presentation are as follows:Presentation Title: "An update on the development of the GCase modulator GT-02287 for Parkinson's disease"Presenter:Jonas Hannestad, M.D., Ph.D., Chief Medical Officer of GainSession Name:In the pipeline: updates from pharma on ongoing preclinical studies and clinical

    4/24/26 8:30:00 AM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carnival Corporation Expands Mexico Maritime Cadet Apprenticeship Program

    World's largest cruise company expands partnership with Maritime & Port University of Mexico to offer onboard training opportunities with Princess Cruises for maritime students in Mexico Addendum signed during Seatrade Cruise Global reinforces the company's proactive approach to supporting maritime education and cultivating a skilled, global maritime workforceMIAMI, April 23, 2026 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK), the world's largest cruise company, expanded its maritime cadet apprenticeship program with Princess Cruises and Maritime & Port University of Mexico, broadening onboard training opportunities for Mexican maritime students and supporting future

    4/23/26 9:30:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bloom Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Bloom Energy from Underperform to Hold and set a new price target of $187.00

    4/14/26 1:08:30 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    BTIG Research initiated coverage on Adobe

    BTIG Research initiated coverage of Adobe with a rating of Neutral

    4/13/26 8:51:07 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Wells Fargo initiated coverage on ATI Inc. with a new price target

    Wells Fargo initiated coverage of ATI Inc. with a rating of Overweight and set a new price target of $175.00

    4/1/26 8:21:42 AM ET
    $ATI
    Steel/Iron Ore
    Industrials

    $ADBE
    $ATI
    $BAND
    $BE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADBE
    $ATI
    $BAND
    $BE
    Financials

    Live finance-specific insights

    View All

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hasbro Announces Preliminary First Quarter 2026 Financial Results with Growth Across Revenue and Operating Profit, Reiterates 2026 Guidance, and Provides Update on Unauthorized Network Access

    Announces Date for First Quarter 2026 Earnings Release and Conference Call Hasbro, Inc. (NASDAQ:HAS), a leading games, IP and toy company, today announced preliminary results for the first quarter ended March 29, 2026, with growth behind continued strength in MAGIC: THE GATHERING. The Company reiterated its full-year guidance. The Company plans to release full first quarter results before the market open on May 20, 2026. Preliminary Q1 2026 Expected Financial Results Today, the Company announced certain unaudited preliminary financial information for the first quarter ended March 29, 2026: Revenue of approximately $970 million to $985 million (+9-11% vs LY) Operating profit of a

    4/23/26 7:00:00 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    PENN Entertainment, Inc. Reports First Quarter Results

    PENN Entertainment, Inc. ("PENN" or the "Company") (NASDAQ:PENN) today reported financial results for the quarter ended March 31, 2026. Jay Snowden, Chief Executive Officer and President, said: "We are pleased to report another solid quarter. Retail Segment Adjusted EBITDAR grew year-over-year and stable trends are carrying into April. In our Interactive segment, continued online casino growth combined with positive trends in Ontario are driving momentum as we prepare for the anticipated July 13 launch of regulated iCasino and online sports betting in Alberta1. Importantly, we are executing on the plan we outlined last quarter, driving Retail and Interactive growth, optimizing corporate o

    4/23/26 7:00:00 AM ET
    $GLPI
    $PENN
    $VICI
    Real Estate Investment Trusts
    Real Estate
    Hotels/Resorts
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Leadership Updates

    Live Leadership Updates

    View All

    QXO to Acquire TopBuild for $17 Billion

    QXO to Become the Second Largest Publicly Traded Building Products Distributor in North America, with More Than $18 Billion of Combined Company Revenue and More Than $2 Billion of Combined Company Adjusted EBITDA Landmark Transaction Is Expected to Be Immediately and Substantially Accretive to QXO's Earnings QXO, Inc. (NYSE:QXO) today announced that it has entered into a definitive agreement to acquire TopBuild Corp. (NYSE:BLD) ("TopBuild") for approximately $17 billion, significantly expanding QXO's scale and capabilities across the building products value chain. The transaction is expected to be immediately and substantially accretive to the company's earnings. TopBuild is the large

    4/19/26 1:00:00 PM ET
    $BLD
    $QXO
    Engineering & Construction
    Consumer Discretionary
    RETAIL: Building Materials

    Nauticus Robotics, Inc. Announces Appointment of New General Counsel

    HOUSTON, April 13, 2026 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ:KITT), a leading innovator in autonomous subsea robotics and software solutions, today announced that Michael Ferrier was appointed General Counsel of the company on April 07, 2026. John Symington recently announced his departure and the two are working together through the transition period. Prior to joining the Company, Mr. Ferrier served as Assistant General Counsel at Berry Corporation from 2022 until March 27, 2026, where he advised on commercial transactions, regulatory compliance, and labor and employ

    4/13/26 8:08:00 AM ET
    $KITT
    Industrial Machinery/Components
    Industrials

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ATI
    $BAND
    $BE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care